-
LCTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Lineage Cell Therapeutics (LCTX)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 46.35 mm | 46.35 mm | 46.35 mm | 46.35 mm | 46.35 mm | 46.35 mm |
Cash burn (monthly) | (no burn) | (no burn) | 1.70 mm | 1.79 mm | 2.12 mm | 1.92 mm |
Cash used (since last report) | n/a | n/a | 4.05 mm | 4.26 mm | 5.03 mm | 4.58 mm |
Cash remaining | n/a | n/a | 42.30 mm | 42.10 mm | 41.32 mm | 41.78 mm |
Runway (months of cash) | n/a | n/a | 24.8 | 23.5 | 19.5 | 21.7 |
13F holders | Current |
---|---|
Total holders | 124 |
Opened positions | 27 |
Closed positions | 17 |
Increased positions | 37 |
Reduced positions | 14 |
13F shares | Current |
---|---|
Total value | 53.36 bn |
Total shares | 148.73 mm |
Total puts | 0.00 |
Total calls | 22.10 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Broadwood Partners | 41.67 mm | $25.00 mm |
Broadwood Capital | 41.67 mm | $20.94 bn |
BlackRock | 10.09 mm | $5.07 bn |
Vanguard | 8.63 mm | $4.34 bn |
Perceptive Advisors | 7.24 mm | $3.64 bn |
Defender Capital | 5.96 mm | $3.00 bn |
Raffles Associates | 5.49 mm | $2.76 bn |
Alyeska Investment | 3.95 mm | $1.98 bn |
Geode Capital Management | 3.69 mm | $1.85 bn |
STT State Street | 2.67 mm | $1.34 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Feb 25 | George A. Samuel III | Common Shares | Payment of exercise | Dispose F | No | No | 0.65 | 2,440 | 1.59 k | 25,820 |
11 Feb 25 | George A. Samuel III | Common Shares | Option exercise | Acquire M | No | No | 0 | 6,076 | 0.00 | 28,260 |
11 Feb 25 | George A. Samuel III | RSU Common Shares | Option exercise | Dispose M | No | No | 0 | 6,076 | 0.00 | 6,075 |
11 Feb 25 | Culley Brian M | Common Shares | Payment of exercise | Dispose F | No | No | 0.65 | 12,547 | 8.16 k | 213,544 |
11 Feb 25 | Culley Brian M | Common Shares | Option exercise | Acquire M | No | No | 0 | 31,249 | 0.00 | 226,091 |
11 Feb 25 | Culley Brian M | RSU Common Shares | Option exercise | Dispose M | No | No | 0 | 31,249 | 0.00 | 31,250 |
27 Jan 25 | Broadwood Partners | Common Shares | Buy | Acquire P | Yes | No | 0 | 0 | 0.00 | 49,560,992 |
27 Jan 25 | Broadwood Partners | Common Shares | Buy | Acquire P | No | No | 0.76 | 7,894,737 | 6.00 mm | 49,560,992 |
27 Jan 25 | Broadwood Partners | Common Warrant Common Shares | Buy | Acquire P | Yes | No | 0.91 | 0 | 0.00 | 7,894,737 |
27 Jan 25 | Broadwood Partners | Common Warrant Common Shares | Buy | Acquire P | No | No | 0.91 | 7,894,737 | 7.18 mm | 7,894,737 |